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Abstract
Background: World Health Organization now recommends the transition from F-75 to ready-to-use therapeutic
foods (RUTF) in the management of severe acute malnutrition (SAM). We described the transition from F-75 to
RUTF and identified correlates of failed transition.
Methods: We conducted an observational study among children aged 6–59 months treated for SAM at Mulago
hospital, Kampala, Uganda. Therapeutic feeding during transition phase was provided by first offering half of the
energy requirements from RUTF and the other half from F-75 and then increasing gradually to RUTF as only energy
source. The child was considered to have successfully transitioned to RUTF if child was able to gradually consume
up to 135 kcal/kg/day of RUTF in the transition phase on first attempt. Failed transition to RUTF included children
who failed the acceptance test or those who had progressively reduced RUTF intake during the subsequent days.
Failure also included those who developed profuse diarrhoea or vomiting when RUTF was ingested.
Results: Among 341 of 400 children that reached the transition period, 65% successfully transitioned from F-75 to
RUTF on first attempt while 35% failed. The median (IQR) duration of the transition period was 4 (3–8) days. The
age of the child, mid-upper arm circumference, weight-for-height z-score and weight at transition negatively
predicted failure. Each month increase in age reflected a 4% lower likelihood of failure (OR 0.96 (95% CI 0.93; 0.99).
Children with HIV (OR 2.73, 95% CI 1.27; 5.85) and those rated as severely ill by caregiver (OR 1.16, 95% CI: 1.02; 1.32)
were more likely to fail. At the beginning of the rehabilitation phase, the majority (95%) of the children eventually
accepted RUTF while only 5% completed rehabilitation in hospital on F-100.
Conclusion: Transition from F-75 to RUTF for hospitalized children with SAM by gradual increase of RUTF was
possible on first attempt in 65% of cases. Younger children, severely wasted, HIV infected and those with severe
illness as rated by the caregiver were more likely to fail to transit from F-75 to RUTF on first attempt.
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Background
Acute malnutrition affects more than 52 million children
worldwide [1]. Of these, an estimated 16 million have the
severe form of acute malnutrition. Patients with severe
acute malnutrition (SAM) are classified into those with
and without medical complications depending on the
presence of medical illness and/or integrated management
of childhood illness (IMCI) danger signs. The treatment of
complicated SAM is divided into stabilization and re-
habilitation phases, with a period of transition in between.
In-patient therapeutic feeding used to involve the use of
two milk-based formulae: F-75 (low protein, low energy)
in stabilization and F-100 (high protein and high energy)
in rehabilitation [2]. Only patients with SAM and medical
complications require hospitalization to stabilize while
those without medical complications can be managed in
the outpatient therapeutic care (OTC) on ready-to-use
therapeutic food (RUTF). WHO recommends the use of
ready-to-use therapeutic food (RUTF) during the rehabili-
tation phase [3]. RUTF is a lipid-based therapeutic food
whose nutritional composition is similar to F-100. Transi-
tion phase feeding refers to the feeding regimen offered to
children during the transition phase [4]. During this
phase, the therapeutic feed is gradually changed from F-75
to F-100 or RUTF. However, there is no clear guideline on
how a gradual transition from stabilization to rehabilita-
tion in the therapeutic feeding can be done [3]. A system-
atic review done in 2012 on transition approach found no
studies that demonstrated the appropriate amounts or
composition of feed to be offered after stabilization [5].
WHO suggests a slow and gradual transition phase feed-
ing in which F-100 or ready-to-use therapeutic food
(RUTF) is introduced in an equal volume as F-75 for 2–
3 days before offering larger volumes intended for catch-
up growth in the rehabilitation phase [3].
In 2013, WHO recommended the direct transition
from F-75 to RUTF in in-patient settings using RUTF as
alternative to previously used F-100 [3]. This would en-
able the rehabilitation phase of children with SAM to be
completed at home while they receive the nutrient-dense
RUTF. The success of the community-based manage-
ment of acute malnutrition (CMAM) approach has been
in part due to availability of RUTF that is used for out-
patient management of uncomplicated SAM [6].
Based on expert opinion, WHO suggests two approaches
to transition from F-75 to RUTF; the first approach in-
volves giving a child RUTF in amounts as prescribed for
the transition phase, if the child does not take the pre-
scribed amount of RUTF, then a top-up with F-75 is given.
The amount of RUTF is gradually increased over 2–3 days
until the child takes the full requirement of RUTF. The sec-
ond approach involves giving the child the prescribed
amount of RUTF for the transition phase. If the child does
not take at least half the prescribed amount of RUTF in the
first 12 h, the RUTF is stopped and the child is given F-75
again. The same approach is re-tried after another 2 days
until the child takes the appropriate amount of RUTF to
meet the energy needs [3].
In addition to the limited evidence to the most appro-
priate approach, limited guidance exists on the estima-
tion of the correct amount of the top-up with F-75 feed
without exceeding the energy requirement for this phase
of management (100–135 kcal/kg/day). We also do not
know the proportion of the children are mostly likely to
fail to transit from F-75 to RUTF on first attempt. We
describe the results from a clinical study where we tran-
sitioned hospitalized children aged 6–59 months with
SAM from F-75 to RUTF, using the first approach by
first providing half of the energy requirements from
RUTF and the other half from F-75 and then increasing
gradually to RUTF as only energy source. We then eval-
uated the correlates of failed transition to RUTF.
Methods
Study design
This was a prospective observational study nested
within a randomized clinical trial (www.isrctn.com,
ISRCTN16454889) investigating the effect of probio-
tics on diarrhoea in children with SAM.
Study population
Using the eligibility criteria for the randomized clinical
trial, a total of 400 children aged 6–59 months with SAM
((weight-for-height/weight-for-length z-score (WHZ/
WLZ) < −3 or mid-upper arm circumference (MUAC)
<11.5 cm or bipedal pitting oedema)) [3] were enrolled
between March 2014 and July 2015. Children whose care-
giver was willing to consent and come back for follow-up
were included. Children in shock, severe respiratory dis-
tress, admission weight less than 4.0 kg and obvious con-
genital anomalies were excluded from the study.
Study setting
The study was conducted in Mwanamugimu Nutrition
Unit (MNU) Mulago Hospital, Kampala, Uganda. Mulago
hospital serves as the national referral hospital receiving
patients from various regions of the country and provides
basic health care for the surrounding population. With an
80 bed capacity, MNU admits approximately 100 children
monthly, providing both in-patient (ITC) and outpatient
therapeutic care (OTC) services for patients with SAM.
Patient management
All patients in the study received standard treatment in
addition to the two probiotic strains or placebo. The
standard patient management at MNU followed the inte-
grated management of acute malnutrition guidelines for
Uganda adapted from the WHO guidelines [3]. Within
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the national referral hospital, enrolled patients were
screened at acute care unit, then transferred to MNU. A
trained nutritionist performed a detailed nutrition assess-
ment while a paediatrician on the study performed evalu-
ation for medical complications. From these two,
hospitalization was considered.
In the stabilization phase, patients received F-75
(Nutriset, Malaunay, France) at 100–135 kcal/kg/day
and were monitored for improving appetite, resolving
medical complications and/or reducing bilateral pedal
oedema. When appetite had improved with the child
completing more than 80% of therapeutic feeds pre-
scribed for a 24 h period, oedema subsided to grade one
or two and medical complications resolving, the patient
was considered ready for transition phase.
During transition phase, the therapeutic feed was grad-
ually changed from F-75 to RUTF, Plumpy’nut®, or F-100
both from Nutriset, Malaunay, France. An acceptance
test that evaluated whether a child could take RUTF was
performed at the start of transition. The acceptance test
was conducted in a separate and quiet corner of the
ward at 12:00 pm every day, just before feeding time,
with the help of the caregiver. The caregiver was in-
formed about the process, asked to wash his/her hands
and instructed to give the child small quantities of RUTF
directly from the sachet for approximately 30 min while
offering safe drinking water. By observation, the study
nutritionist considered the test passed if the child com-
pleted at least approximately a third of the 92 g sachet.
Taking into consideration the recommended energy in-
take for the transition phase, 100–135 kcal/kg/day, the
total intake for the day was calculated and subdivided
such that on the first day of transition, 50 kcal/kg was
obtained from RUTF and the other 50 kcal/kg from F-
75. For the subsequent days, more RUTF than F-75 was
prescribed while maintaining the 100–135 kcal/kg/day
intake until the child received RUTF alone. A child was
considered successfully transitioned on the first attempt
from F-75 to RUTF if he/she took 135 kcal/kg/day. The
food intake, quantities and tolerance of RUTF were
closely monitored by the study nutritionist who also
made adjustments in the feeding plan daily.
Failed transition
In this study, failed transition to RUTF on first attempt
was defined as a child who failed the acceptance test
despite the improved appetite with F-75 and clinical well
state or one who had progressively reduced RUTF intake
during the subsequent days or one who developed pro-
fuse diarrhoea or vomiting when RUTF was ingested.
Those who failed transition to RUTF but were clinically
well, received F-100.
During the transition period, the study team moni-
tored the child for appetite, vomiting feeds, profuse
diarrhoea and dehydration, re-accumulation of oedema,
clinical deterioration in the respiratory rate, pulse rate
and temperature or development of negative reactions to
the RUTF. In the presence of any of these symptoms
and signs, the clinician transferred the child back to F-
75 in stabilization phase.
For those that successfully transited to RUTF on the
first attempt, they were transferred to complete the re-
habilitation phase in the out-patient therapeutic care
(OTC). At discharge from hospital, RUTF was prescribed
at 200 kcal/kg/day and a follow-up appointment was
given. For children who simply rejected RUTF with no
negative reactions, another attempt to give RUTF was
done after 2–3 days in rehabilitation phase while for those
that developed profuse watery diarrhoea and vomiting, no
further attempts to RUTF were made. These children
completed the rehabilitation phase in hospital on F-100.
Data collection procedures
A case report form was used to document all data ob-
tained from the caregiver and patient examination find-
ings. At admission, data was collected on age, sex, date
of birth, maternal age and education level, previous
medical and treatment history of the child and the pre-
senting symptoms. The caregivers were asked to grade
the severity of the child’s illness at admission on a visual
analogue scale (VAS) ranging from 0 to 10. A full phys-
ical examination to include grade of oedema, dehydra-
tion status, skin changes and vital signs (respiratory rate,
pulse rate and temperature) was performed by a study
medical doctor.
Body weight was measured using a digital scale (Seca
813, Hamburg, Germany) to the nearest 100 g. Length/
height was measured using an infant length board (In-
fant/Child Shorr-Board®, Maryland, USA) and mid-upper
arm circumference (MUAC) using colour coded tapes
(Child 11.5 red/pac-50, UNICEF), both to the nearest
1 mm. Triple measurement for weight, length/height
and MUAC were taken and an average obtained. An-
thropometric z-scores for weight-for-height (WHZ) and
height-for-age (HAZ) were computed using WHO
Anthro version 3.2.2. The study paediatrician together
with the nutritionists conducted a daily clinical assess-
ment of the study patients including monitoring of vital
signs, grade of oedema, appetite, type and amount of
feeding regimens given through stabilization, transition
and rehabilitation phases.
Laboratory tests
Blood sampling was performed at admission, discharge
and 8 weeks after discharge. At admission, 4 ml of ven-
ous blood was collected into heparinized evacuated
tubes (Becton Dickinson, USA) to run tests for HIV,
blood cell counts, haemoglobin and C-reactive protein
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(CRP). HIV serological testing was done using rapid tests
(Determine HIV-1/2, Abbott Laboratories, USA) and
positive test results were further confirmed using HIV 1/2
Stat-Pak Dipstick Assay kit. For children less than
18 months, HIV status was confirmed by an HIV DNA
PCR test at Baylor HIV clinic. Samples were analyzed for
cell blood counts and haemoglobin at the Uganda cancer
institute laboratory. A copy of the results was provided to
doctors on the ward to support patient management. A
sample of the blood was centrifuged at 1300–2200 g for
10 min, stored at −80 °C and shipped on dry ice to the la-
boratory at Department of Nutrition Exercise and Sports,
University of Copenhagen, where C-reactive protein was
analyzed using Pentra 400, (Horiba ABX, France).
Data analysis
All data was entered into Epidata version 3.1 and ana-
lyzed using Stata version 12. Descriptive statistics using
means, medians and proportions was used to present
the socio-demographic characteristics, maternal charac-
teristics and laboratory data. To determine the strength
of association for the predictors of failed transition from
F-75 to RUTF, a series of logistic regression models were
fitted. Duration of stabilization phase, HIV infection, se-
verity of illness of the child at admission in addition to
age and sex were evaluated as potential confounders.
Each of these factors did not change the unadjusted
odds ratio by more than 10% hence not included in the
final regression model. The independent variables were
adjusted for age and sex. P-values below 0.05 were statis-
tically significant.
Results
Socio-demographic characteristics
The mean (±SD) age of the children that reached transition
phase was 17.1 (±8.7) months and 42% were females
(Tabl 1). Their mean WHZ and HAZ were −2.5 (±1.5) and
−3.1 (±1.4), respectively. At admission, 66% of children pre-
sented with oedema. The mean maternal age was 25 (±5.8)
years, with 185 (58%) of the mothers having attained pri-
mary level education or lower (data not presented).
Transition from F-75 to RUTF
Of 400 children enrolled, 341 (85%) reached transition
phase (Fig. 1). Of these, 223 (65%) succeeded in transi-
tion from F-75 to RUTF on the first attempt while 118
(35%) failed (Fig. 1). It took on average 1.4 (±1.4) days to
gradually change the feed from RUTF with top up of F-
75 to RUTF alone during the transition period. Twelve
percent (27/223) of children transitioned directly from
F-75 to RUTF without the need for top-up with F-75.
Overall, the median (IQR) duration for the entire transi-
tion period was 4 (3–8) days, which included time to tran-
sit from F-75 to RUTF or F-100 and resolution of medical
complications. However, this duration was longer for
those that failed transition to RUTF on the first attempt,
[4 (3–6) days vs 7.5 (4 .0–11) days, p < 0.01]. There was
no difference in number of days in stabilization phase
among those succeeding compared to those failing to
transition to RUTF (10.5 vs. 9.6 days, p = 0.15).
Table 1 Characteristics of 341 severe acute malnutrition
children reaching transitiona
Child characteristics
Agea, months 341 17.1 ± 8.7
Female sex, n (%) 341 143 (42%)
How sick at admission, VASb 340 6.0 ± 1.8
Weight-for-height z 339 −2.5 ± 1.5
Weight for height z score
≥ −2 125 (37%)
< −2 and > − 3 65 (19%)
< −3 and > −4 90 (27%)
< −4 and > −5 44 (13%)
≤ −5 14 (4%)
Height-for-age z 339 −3.1 ± 1.4
Mid-upper arm circumference, cm 341 11.6 ± 1.5
HIV status, n (%) 323
Negative 229 (70.9%)
Positive 32 (10%)
Exposed, negative 62 (19%)
Symptoms on admission, n (%)
Cough 340 225 (66%)
Diarrhea 340 194 (57%)
Fever 340 180 (53%)
Clinical data on admission, n (%)
Oedema 341
Grade 1 22 (7%)
Grade 2 64 (19%)
Grade 3 139 (41%)
Flaky paint dermatosis 341 22 (6%)
Laboratory data on admission
Serum C-reactive protein, mg/dl
> 10 303 183 (60%)
Hemoglobin 259 8.8 ± 2.1
Clinical data at transition
Oedema, n (%) 341
Grade 1 58 (17%)
Grade 2 5 (2%)
Weight, kg 294 6.7 ± 1.6
No. of days with diarrhoea in stabilization 339 4.1 ± 3.9
aData are number of children with data, and mean ± standard deviation or
number (%)
b visual analogue scale
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The children that were successfully transitioned to
RUTF at the first attempt were then transferred to
complete rehabilitation in OTC. On the second attempt
for acceptance of RUTF during rehabilitation phase, 101
(86%) of the 118 that received F-100 now accepted the
prescribed RUTF and were transferred to OTC to
complete rehabilitation. The remaining 14% (17/118)
children did not accept RUTF at all. The children that
did not accept RUTF at all continued with the rehabilita-
tion phase to attain catch-up growth in hospital while
receiving F-100 and allowed home after full recovery on
locally available foods (Fig. 1).
Correlates of failed transition
The age of a child was negatively associated with failed
transition from F-75 to RUTF on the first attempt. An
odds ratio of 0.96 (95% confidence interval (CI) 0.93;
0.99) for age reflects a 4% lower likelihood of failure to
transition from F-75 to RUTF for each month increase
in age (Table 2). A WHZ lower than −3 was associated
with higher odds of failure (Table 2). Increasing MUAC
(OR 0.79, 95% CI 0.68; 0.94) and weight at time of tran-
sition (OR 0.68, 95% CI: 0.53; 0.86) were associated with
a lower risk of failure. We found a 32% reduction in the
risk of failure for every kilogram increase in the weight
at the time of transition. The HIV positive children were
more likely to fail transition to RUTF (OR 2.73, 95% CI:
1.27; 5.85). The severity of illness of the child as rated by
the caregiver at admission using visual analogue scale
was found to be associated with failure (OR 1.16, 95%
CI: 1.02; 1.32). Neither symptoms of cough, diarrhoea,
fever nor presence of oedema whether at admission or
at the time of transition were associated with failure
(Table 2).
Transfer back to stabilization
Of the 341 children that reached transition phase, 51
(15%) were transferred back to stabilization phase. The
clinical characteristics of the children on the day of trans-
fer back to stabilization are presented in Table 3. Nearly
half (47%) of those transferred back to stabilization had an
increased respiratory rate and 18% were diagnosed to have
severe pneumonia (Table 3). Age, lower WHZ score,
MUAC and weight at transition were negative predictors
of transfer back to stabilization (Table 4).
Discussion
WHO recommends a gradual process of transition from
F-75 to RUTF or F-100 [3]. However, the approach to
transition process especially to RUTF is lacking in evi-
dence. This study describes a method of gradual transi-
tion from F-75 to RUTF with a structured step up of
Failed transition from F-
75 to RUTF/ given F-100
(n = 118)
Successful transition from
F-75 to RUTF 
(n= 223)
esahp
noitatilibahe
R
Children enrolled
(N=400)
RUTF RUTF
F-100 RUTF
(n=101)
Children reaching 
transition phase
(N= 341)
F-100 F-100
(n=10)
F-100 others
(n=7)
noitisnar
T
Died (n=39)
Self-discharge (n=15)
Excluded (n=5)
esahp
noitazilibatS
Transfer back to 
stabilization
(n=51)
(n=223)
Fig. 1 Proportion of children with severe acute malnutrition that failed or succeeded transition from F-75 to RUTF on first attempt. 118 children failed
transition to RUTF. Those who failed were children who failed the acceptance test or who had progressively reduced RUTF intake during the subsequent
days or developed negative reactions such as profuse diarrhoea or vomiting when RUTF was ingested. Those who failed were given F-100. At beginning
of rehabilitation phase, another attempt to RUTF was done for those who had failed transition to RUTF. Of the 118 children, 101 changed feed from F-100
to RUTF, while 10 children remained on F-100 and 7 received other feeds such as porridge. Among the 341 children that were transition, 51 developed
signs and symptoms of clinical deterioration while in either transition or rehabilitation phase and were transferred back stabilisation
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amount of RUTF to be given during the transition
phase. We found that 65% of children with SAM transi-
tioned from F-75 to RUTF on first attempt after the
stabilization phase while 35% failed. This provides good
evidence to support the recommendation by WHO. A
recent study conducted in Malawi [7] has further
showed that the introduction of RUTF during transition
phase has no effect on the stool pH or duration of hos-
pital stay compared to F-100. Furthermore, we note that
the majority (95%) of the children in this study later
accepted RUTF in the rehabilitation phase with only 5%
not taking RUTF at all. That the majority of the children
eventually accept RUTF as they begun the rehabilitation
phase is relevant information because it implies that many
more children can then be managed on an outpatient
basis following stabilization of their medical complica-
tions. Since endorsement of the CMAM approach by the
UN agencies [8], the use of RUTF in the management of
uncomplicated SAM has saved millions of lives of children
through improved coverage of nutrition programmes,
Table 2 Correlates of failed transition from F-75 to RUTF among 341 children treated for severe acute malnutritiona
Unadjusted Age and sex adjusted
OR 95% CI p OR 95% CI P
Child characteristics
Age, months 0.96 0.93;0.99 0.02 0.96 0.93;0.99 0.01
Female sex, n (%) 0.83 0.53;1.31 0.42 0.80 0.51;1.28 0.37
How sick, VASb 1.14 1.01;1.29 0.03 1.16 1.02;1.32 0.02
HIV status, n (%)
Exposed 1.03 0.56;1.86 0.91 0.96 0.52;1.79 0.92
Positive 2.58 1.22;5.48 0.01 2.73 1.27;5.85 0.02
Weight-for-height z 0.77 0.68;0.91 0.001 0.82 0.69; 0.95 0.01
Weight-for-height z
≥ −2 ref
< −2 and > − 3 1.37 0.71; 2.68 0.34 1.31 0.67; 2.57 0.42
< −3 and > −4 2.42 1.35; 4.34 0.003 2.13 1.17; 3.88 0.01
< −4 and > −5 2.10 1.01; 4.33 0.04 1.81 0.86; 3.81 0.12
≤ −5 3.03 0.98; 9.32 0.05 2.52 0.81; 7.94 0.11
Height-for-age z 0.91 0.78;1.06 0.24 0.86 0.72;1.02 0.07
MUAC, cm 0.77 0.66;0.89 0.001 0.79 0.68;0.94 0.01
Symptoms on admission (%)
Cough 1.05 0.65;1.69 0.83 1.04 0.64;1.67 0.89
Diarrhea 1.03 0.66;1.62 0.87 1.00 0.62;1.59 0.99
Fever 1.27 0.81;1.98 0.30 1.27 0.80;2.01 0.31
Clinical signs on admission (%)
Oedema
Grade 1 1.41 0.56;3.54 0.46 1.55 0.61;3.93 0.35
Grade 2 1.08 0.58;2.03 0.79 1.20 0.63;2.28 0.57
Grade 3 0.68 0.41;1.16 0.16 0.80 0.46;1.38 0.42
Flaky paint dermatosis 1.08 0.44;2.66 0.86 1.12 0.45;2.78 0.80
Laboratory data on admission
C-reactive protein, mg/l
> 10 0.97 0.60;1.57 0.92 0.98 0.61;1.60 0.96
Hemoglobin, g/dl 0.96 0.85;1.08 0.52 0.96 0.84;1.08 0.52
Weight at transition, kg 0.73 0.61;0.86 <0.001 0.68 0.53;0.86 0.002
No. of days with diarrhoea during stabilization 1.01 0.95;1.07 0.80 0.99 0.94;1.06 0.97
No. of days of stabilization phase 1.02 0.98;1.07 0.31 1.02 0.97;1.06 0.36
aData are odds ratio (OR), 95% confidence interval (CI) and p-values
bvisual analogue scale
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reduced mortality rates, timely treatment of SAM and re-
duced costs of hospital care [6, 9–11]. This study provides
evidence that supports the direct transition from F-75 to
RUTF and subsequently these children are managed in
the out-patient therapeutic programmes. It is also import-
ant to note that not all children were able to transition
successfully from F-75 to RUTF at the same speed.
We found that the children that transitioned success-
fully from F-75 to RUTF on the first attempt, the gradual
increase in RUTF till they were on RUTF alone took be-
tween 1 and 2.8 days. This is consistent with the current
recommendation of 2–3 days [3] hence further
strengthens the current recommendation. In this study,
the entire transition period lasted 3–8 days among all chil-
dren that reached transition. This finding is in line with
the WHO 1999 guidelines [2] showing transition period
to last for 3–7 days. However this transition period was
longer for those that failed to transit smoothly to RUTF.
Predictors of failed transition
Increasing age was associated with a lower risk of failure.
Younger children perhaps could have some difficulty
with the consistency of RUTF in its current semi-solid
state. Coupled with the physiological changes of reduced
muscle mass to include the muscles of mastication, in-
take of RUTF may be somewhat affected compared to F-
75 or F-100 that is in liquid form, easier to drink and
swallow. It is also probable that these children with mal-
nutrition also have delayed introduction of complemen-
tary feeds and commonly the first complementary feeds
are fluid in consistency. Studies in an urban district of
Nairobi [12] and a rural district in Uganda [13] showed
higher probability of receiving liquid to a semisolid or
solid complementary food among children in the devel-
oping countries. Another study conducted in the west-
ern rural district in Uganda [14] found 19% of children
in the community aged 6–8 months were still exclusively
breastfeed instead of receiving complementary feeds. A
review on the global perspective of complementary feed-
ing [15] revealed that a cereal based porridge often with
plenty of water was the main complementary food given
in many developing countries. A study conducted in
Bangladesh [16], 78% of malnourished pregnant and lac-
tating women found the RUTF unacceptable. They fur-
ther suggested making changes to taste, smell and
consistency to make it more liquid [16].
Furthermore, we found that wasting as measured by
decreasing WHZ and MUAC were associated with a
higher risk of failure. The odds of failure were higher
with decreasing initial WHZ. Children with WHZ less
than −5 SD were 3 times more likely to fail to transit to
RUTF on the first attempt. Probably the most wasted
children having been through longer periods of starva-
tion in addition to functional and structural changes in
the body organs due to reductive adaptation will simi-
larly require longer period to re-adapt when therapeutic
feeding is initiated.
HIV infection and severity of illness as reported by the
caregiver were positively associated with higher risk of
failure to transit to RUTF. Contrary to this finding, stud-
ies conducted in Tanzania [17] and Malawi [18], RUTF
Table 3 Clinical characteristics at the time of transfer back to
stabilization 1
Clinical characteristics * N = 51
Weight, kg 6.15 ± 1.32
Temperature, °C 36.9 ± 0.83
Pulse rate 2, b/min 128 ± 15
Oxygen saturation3, (%) 92.3 ± 5.8
Visual analogue scale, VAS 3.0 ± 3.1
Respiratory rate
Normal 27 (53%)
Increased 24 (47%)
Chest in-drawing
No 41 (80%)
Yes 10 (20%)
Breath sounds on auscultation
Normal 41 (80%)
Crepitations 6 (12%)
Diminished 1 (2%)
Pneumonia
None 37 (72%)
Pneumonia 5 (10%)
Severe pneumonia 9 (18%)
Oedema
None 45 (88%)
Grade 1 3 (6%)
Grade 2 2 (4%)
Grade 3 1 (2%)
ReSoMal prescribed4
None 33 (65%)
Plan A 10 (20%)
Plan B 8 (15%)
Appetite
None 5 (10%)
Poor 15 (29%)
Good 31 (61%)
1Data presented are mean (SD) or n (%)
2N = 13
3N = 7
4ReSoMal Plan A; 30-50mls of ReSoMal per loose stool for children with no
dehydration, ReSoMal plan B; 5mls/kg for first 30 min followed by 5-10mls/kg
of ReSoMal for 6–8 h given for some or severe dehydration
*A child could have one or more of these characteristics
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has been used successfully among the HIV infected chil-
dren without medical complications during the home-
based therapy of SAM with good results in weight gain.
However the study in Malawi [18] showed only 56% vs
84% of children with full recovery in WHZ among the
HIV-infected children compared to the HIV-negative
children respectively. This was attributed to develop-
ment of cough, fever and diarrhoea. A study by Zeitz et
al. [19] documented lactase deficiency in nearly 50% in
HIV patients hence increasing the risk of malabsorption
and diarrhoea. This points to probable differences in the
metabolic alterations in HIV-infected compared to the
HIV-negative children that could equally influence tran-
sition to RUTF. Use of RUTF in HIV-infected children
merits further evaluations to improve nutrition
outcomes.
We found 15% of the children in this study were
transferred back to stabilization phase after successful
transition due to clinical deterioration with symptoms
and signs of increased respiratory rate, pneumonia and
diarrhoea with dehydration. Systematic reviews [5, 20]
indicate that clinical manifestations of respiratory dis-
tress, cardiac failure or lethargy while in transition phase
may often be misinterpreted for sepsis or pneumonia yet
Table 4 Correlates of transfer back to stabilization among 341 children treated with severe acute malnutrition a
Unadjusted Age and sex adjusted
OR 95% CI p OR 95% CI p
Child characteristics
Age, months 0.97 0.93; 0.99 0.04 0.96 0.93; 0.99 0.04
Female sex, n (%) 0.78 0.47; 1.29 0.33 0.76 0.45; 1.26 0.29
Severity of illness, VASb 0.83 0.72; 0.94 0.01 0.83 0.73; 0.95 0.01
HIV status, n (%)
Exposed 0.74 0.37; 1.49 0.40 0.72 0.36; 1.47 0.37
Positive 1.62 0.73; 3.56 0.23 1.68 0.75; 3.72 0.20
Weight-for-height z 0.72 0.61; 0.86 <0.001 0.75 0.62; 0.89 0.002
Height-for-age z 0.95 0.80; 1.13 0.59 0.91 0.76; 1.09 0.33
MUAC, cm 0.77 0.64; 0.91 0.003 0.79 0.66; 0.95 0.01
Symptoms on admission (%)
Cough 1.16 0.68; 1.97 0.58 1.14 0.67; 1.95 0.62
Diarrhea 0.92 0.56; 1.51 0.73 0.87 0.53; 1.45 0.61
Fever 0.94 0.57; 1.54 0.81 0.94 0.57; 1.55 0.81
Clinical signs on admission (%)
Oedema
Grade 1 1.12 0.42; 3.00 0.81 1.22 0.45; 3.28 0.69
Grade 2 0.80 0.40; 1.61 0.54 0.86 0.43; 1.75 0.68
Grade 3 0.55 0.31; 0.99 0.05 0.63 0.34; 1.15 0.13
Flaky paint dermatosis 0.91 0.32; 2.54 0.855 0.94 0.33; 2.66 0.91
Laboratory data on admission
C-reactive protein, mg/l
> 10 0.87 0.51; 1.47 0.61 0.88 0.52; 1.49 0.64
Hemoglobin, g/dl 1.12 0.98; 1.29 0.09 1.13 0.99; 1.29 0.06
Clinical data at transition
Edema at time of transition
Grade 1 0.53 0.24; 1.12 0.10 0.53 0.23; 1.16 0.11
Grade 2 1.91 0.31; 11.6 0.48 3.28 0.47; 22.45 0.23
Weight at transition, kg 0.72 0.58; 0.87 0.001 0.64 0.48; 0.84 0.001
Diarrhoea during stabilization 1.02 0.96; 1.09 0.39 1.02 0.96; 1.08 0.54
Duration of stabilization phase 0.97 0.92; 1.02 0.27 0.96 0.92; 1..02 0.24
aData are odds ratio (OR), 95% confidence interval (CI) and p-values
b visual analogue scale
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they are the manifestations of refeeding syndrome. A re-
view of refeeding syndrome [21] highlighted that the se-
verely wasted individuals with prolonged fasting or low
energy diet intake were at a higher risk of refeeding syn-
drome. Refeeding syndrome commonly presents with
symptoms and signs of hypophosphatemia and hypo-
magnesaemia such as respiratory distress, weakness, car-
diac failure, nausea and diarrhoea [21]. However recent
studies conducted in Uganda [22, 23] showed increasing
levels of plasma phosphate in the transition phase and at
discharge among children managed for SAM. This fol-
lows the WHO recommendations that improved phos-
phate content in the therapeutic feeds hence refeeding
syndrome is unlikely.
We did not find any correlation between failed transi-
tion and oedema either at admission or at the time of
transition. This supports the recommendation for the
use of RUTF when oedema is grade II or I as is done in
the outpatient therapeutic programmes [3].
Other factors we would have liked to measure as po-
tential effect modifiers are the timing of introduction of
complementary feeds, the type of complementary feeds
introduced and previous exposure to RUTF. The previ-
ous exposure to RUTF in the children would probably
ease the intake of RUTF since this is a taste and
consistency the child has been exposed to or if the child
did not like it previously, he would reject it when it is
given this time. During the selection of study partici-
pants, we excluded the children with cerebral palsy who
are known to have feeding difficulties. This group of
children would have modified the effect on the estimate
as they are more likely to fail.
Strengths and limitations
This is among the first studies that describes the transi-
tion feeding of hospitalized children with SAM following
the recent WHO recommendations. The study was con-
ducted in a controlled environment during a clinical
trial. This facilitated close monitoring of the feeding in
children both during day and night.
Amongst the study limitations, firstly, the study selec-
tion criteria did not include the severely ill children and
those with disabilities hence may affect the external val-
idity of the findings. Secondly, the process of determin-
ing whether a child was ready for transition phase as
this process is relatively subjective and dependent on the
return of appetite. There is no literature that demon-
strates sensitivity or specificity of the return of appetite
in correctly identifying those ready for transition. It is
also not certain whether the refusal of RUTF was be-
cause of the new taste to the child rather than a different
consistency from the F-75 previously taken during
stabilization. However the process and monitoring of
transition phase was conducted by well trained and
experienced nutritionists. Lastly, we were not able to carry
out blood tests for serum electrolytes such as phosphate,
magnesium, and potassium during transition phase. Re-
feeding syndrome is associated with hypophosphatemia,
hypomagnesemia and hyperkalemia. Therefore we cannot
say for sure that signs of respiratory distress, diarrhoea ob-
served in the children who were transferred back to
stabilization were a result of refeeding syndrome.
Conclusion
Transition from F-75 to RUTF during the transition phase
for hospitalized children with SAM was possible on first at-
tempt in the majority of children with SAM. The method
of first providing half the energy requirements using RUTF
and the remaining half by F-75 then gradually increasing to
RUTF as the only source of energy during transition pro-
vides guidance for practitioners managing hospitalized chil-
dren with SAM.Younger children, severely wasted, HIV
infected and those reported to be severely ill by the care-
giver were more likely to fail transition to RUTF on first at-
tempt. The transition process from F-75 to RUTF warrants
further research to evaluate the most appropriate method
of transition with minimal failures and to advance in more
objective and field appropriate methods to determine readi-
ness to transit or stabilization of metabolic alterations in
children with SAM.
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